Arcella Bio‘s platform prioritises mechanisms, targets, known compounds and patient-level data to accelerate a degree of confidence in strategic decisions, for early-stage drug discovery, clinical trial conduct, and patient population stratification. The Platform is powered by proprietary algorithms that analyse over 35 million scientific publications (full text and abstracts), clinical trials, and genomics data, supported by 15,000 databases and custom ontologies, creating over 250 million interactome relationships.